In a pre-Covid world, vaccine development was a stringently regulated process that took 10-12 years of research and trials before reaching the American population. As a second wave of infection sweeps through the nation, several pharmaceutical companies could have newly created injections on the market by the end of the year.
Heavily aided by the Trump administration’s Operation Warp Speed, which has a goal of rapidly producing effective vaccines that adhere to standard safety guidelines by January, three different drug makers have announced the development of vaccine candidates with high efficacy rates.
Here’s everything you need to know:
